Cannabis trade associations shared their legislative priorities around out-of-state ownership, social equity, medical cannabis, and synthesized cannabinoids.
Prevention and social equity advocates would convene online, while a cannabis trade association would host state legislators, regulators, and researchers for in person discussion.
Members adopted an algorithm for determining disproportionately impacted areas (DIAs) but postponed consideration of two social equity application process recommendations.
WSLCB leadership briefed the committee on “Cannabis Regulatory Issues and Implementation of Recent Legislation” after Gillian Schauer described delta-8-THC “health and safety risks.”
As the Cannabis Science Task Force wrapped up its work and moved to fade into its sunset, the Social Equity Task Force was prepared to adopt its most ambitious legislative agenda yet.
A request bill to modify the timeline for Ecology to take on lab accreditation was shelved following “stakeholder research,” while potential legislation to create a lab standards body carried on.
Director of Legislative Relations Chris Thompson went over the status of two potential agency request bills (lab standards, cannabinoid regulation) and an upcoming briefing to lawmakers.
CANNRA Executive Director Gillian Schauer shared her personal view of the current state of cannabis policymaking nationwide before addressing associated public health topics.
The work group reached consensus on recommendations to the task force covering additional social equity retail licenses, license mobility, and a market share metric for equity.
A busy week inclusive of hearings on a local ban, medical cannabis taxation, social equity, and product testing would culminate in a legislative work session setting the stage for 2022.
